Launchmetrics launches visual content platform and invests in AI
Launchmetrics' expansion into the visual content sector began in 2019 with the acquisition of Italian company IMAXtree. The deal underscored the company's interest in...
Search
All
Launchmetrics' expansion into the visual content sector began in 2019 with the acquisition of Italian company IMAXtree. The deal underscored the company's interest in...
Siolta Therapeutics, a clinical-stage biopharmaceutical company developing novel targeted live biotherapeutic products (LBPs) to prevent and treat diseases of high unmet...
String Bio (String) and Woodside Energy are collaborating on potential production of sustainable protein ingredients from greenhouse gases.
Woodside Energy has invested...
Intento Design, a Paris-based french company, developing and commercializing intelligent analog design automation tools to accelerate and secure chip production, announces...
Launched in December 2021 by Seventure Partners , Blue Forward Fund™ is the first European fund dedicated to blue economy...
GB1211, Galecto's galectin-3 inhibitor, has shown potent anti-tumor effects and increased efficacy of checkpoint inhibition in pre-clinical models
Enterome, a clinical stage biopharmaceutical company developing first-in-class immunomodulatory drugs based on its bacterial Mimicry drug discovery platform, today announces...
Enterome, a clinical stage biopharmaceutical company developing first-in-class immunomodulatory drugs based on its bacterial Mimicry drug discovery platform, today announces...